Most Read News

The NFO is available for subscription from April 23 to May 07, 2025.

The purchase is anticipated to enhance Syngene's position in the biologics contract development and manufacturing organization (CDMO) arena, specifically in the US market.

The company reported an operating EBITDA of ₹343.60 Crore in the quarter four of FY25. It registered a growth of 8.4% on a year-on-year basis.

On a quarter-on-quarter basis, the EBITDA grew sharply by 40.02% over ₹116.7 crore seen in Q3FY25.

Out of the ₹752 crore investment, ₹603 crore will be utilized upfront to reduce debt across Samhi’s portfolio and cover transaction-related expenses.

This is Suzlon's second large order from NTPC Green Energy in the past eight months and is a testimonial to the consolidation of their strategic alliance.

However, Dalmia Bharat’s Q4 revenue from operations slipped 5% on a year-on-year basis to ₹4,091 Crore as compared to ₹4,154 Crore.

RBI has stated in the April 2025 MPC meet that inflation looks to stay close to 4% on a durable basis

Though there was a fall in quarterly losses, TTML's operating revenue fell by 5%, coming down to ₹308.27 crore in Q4 FY25 from ₹323.29 crore in Q4 FY24.

UltraTech Cement, Bajaj FinServ, Bajaj Finance are the stocks that hits 52-week high in Sensex and Nifty